PubMed for Bookshelf ID: 4986850

Year	Number of Results
1984	1
1989	1
1991	2
1992	1
1994	1
1995	2
1997	1
1998	1
2004	1
2014	1
2015	1
2024	0

1

Montecucco A, Zanetta F, Biamonti G. Montecucco A, et al. EXCLI J. 2015 Jan 19;14:95-108. doi: 10.17179/excli2015-561. eCollection 2015. EXCLI J. 2015. PMID: 26600742 Free PMC article. Review.

2

Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: a Taiwanese Gynecologic Oncology Group study.

Chen CA, Lin H, Weng CS, Wen KC, Lu CH, Chou HH, Huang YF, Kang CY, Ho CM, Yu MH, Chou CY. Chen CA, et al. Eur J Cancer. 2014 Dec;50(18):3161-7. doi: 10.1016/j.ejca.2014.10.006. Eur J Cancer. 2014. PMID: 25459394

3

Etoposide: discovery and medicinal chemistry.

Meresse P, Dechaux E, Monneret C, Bertounesque E. Meresse P, et al. Curr Med Chem. 2004 Sep;11(18):2443-66. doi: 10.2174/0929867043364531. Curr Med Chem. 2004. PMID: 15379707 Review.

4

Etoposide: four decades of development of a topoisomerase II inhibitor.

Hande KR. Hande KR. Eur J Cancer. 1998 Sep;34(10):1514-21. doi: 10.1016/s0959-8049(98)00228-7. Eur J Cancer. 1998. PMID: 9893622 Review.

5

Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.

de Wit R, Stoter G, Kaye SB, Sleijfer DT, Jones WG, ten Bokkel Huinink WW, Rea LA, Collette L, Sylvester R. de Wit R, et al. J Clin Oncol. 1997 May;15(5):1837-43. doi: 10.1200/JCO.1997.15.5.1837. J Clin Oncol. 1997. PMID: 9164193 Clinical Trial.

6

Etoposide dosage and pharmacodynamics.

Joel SP, Shah R, Slevin ML. Joel SP, et al. Cancer Chemother Pharmacol. 1994;34 Suppl:S69-75. doi: 10.1007/BF00684867. Cancer Chemother Pharmacol. 1994. PMID: 8070031 Review.

7

A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days.

Thompson DS, Greco A, Miller AA, Srinivas NR, Igwenezue KB, Hainsworth JD, Schacter LP, Kaul S, Barbhaiya RH, Garrow C, et al. Thompson DS, et al. Clin Pharmacol Ther. 1995 May;57(5):499-507. doi: 10.1016/0009-9236(95)90034-9. Clin Pharmacol Ther. 1995. PMID: 7768072 Clinical Trial.

8

Etoposide: twenty years later.

Hainsworth JD, Greco FA. Hainsworth JD, et al. Ann Oncol. 1995 Apr;6(4):325-41. doi: 10.1093/oxfordjournals.annonc.a059180. Ann Oncol. 1995. PMID: 7619747 Free article. Review.

9

Etoposide: a semisynthetic epipodophyllotoxin. Chemistry, pharmacology, pharmacokinetics, adverse effects and use as an antineoplastic agent.

Sinkule JA. Sinkule JA. Pharmacotherapy. 1984 Mar-Apr;4(2):61-73. doi: 10.1002/j.1875-9114.1984.tb03318.x. Pharmacotherapy. 1984. PMID: 6326063 Review.

10

Etoposide: an update.

Fleming RA, Miller AA, Stewart CF. Fleming RA, et al. Clin Pharm. 1989 Apr;8(4):274-93. Clin Pharm. 1989. PMID: 2653712 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year